Your Cart is Empty
Biotic 7, 30 caps
$ 31.50
Free Shipping On Orders over $50
Nutritionist Approved
60-Day Return Guarantee
DESCRIPTION
Biotic 7 is a seven-strain probiotic, containing six of the most researched strains of bacteria (20 billion CFUs total), plus 2 billion CFUs of saccharomyces boulardii. Saccharomyces boulardii is a non-pathogenic yeast that cleans out other pathogens (bad microbes) in the gut so the good strains of bacteria can then colonize the intestinal tract instead.
The Biotic 7 capsules are made of a digestive-resistant complex, making it is a delayed release. This means that these critical microbes can withstand transit through the harsh stomach and upper intestinal environments and get deposited in the appropriate area of the digestive tract.
Research has exploded in recent years surrounding the intestinal flora and its importance to our everyday health. We need enough good bacteria (probiotics) in our digestive tract to have optimal breakdown and absorption of our food. Clinical evidence suggest probiotics may:
- Support a healthy gut microbiome
- Support a healthy inflammatory response
- Support a healthy immune function
- Support digestive function
- Support a healthy mood
INGREDIENTS
Serving Size: 1 capsule
Servings per Container: 30
Pill Size: #1 Veggie Cap
Ingredients:
Lactobacillus paracasei UAL-pc-04™†† 5.926 Billion CFU†*
Bifidobacterium lactis UABla-12™†† 5.185 Billion CFU†*
Lactobacillus acidophilus UALa-01™†† 4.444 Billion CFU†*
Lactobacillus plantarum UALp-05™†† 2.963 Billion CFU†*
Saccharomyces boulardii DBVPG®††† 2 Billion CFU†*
Bifidobacterium bifidum UABb-10™†† 0.741 Billion CFU†*
Lactobacillus rhamnosus UALr-06™†† 0.741 Billion CFU†*
* Daily Value (DV) not established.
Other Ingredients: Microcrystalline cellulose, digestive resistant capsule (hypromellose, gellan gum), vegetable magnesium stearate.
Gluten Free | Dairy Free | Non-GMO | Vegetarian | Vegan
All NutriKey brand supplements are Pharmaceutical Grade and produced in Certified GMP (cGMP) facilities. All NutriKey brand supplements meet or exceed cGMP standards and are third party tested.
† At time of manufacture.
†† These trademarks are the property of UAS Labs.
††† DBVPG® is a registered trademark material of Gnosis S.p.A.
DIRECTIONS
Directions: Take one capsule daily or as directed by your healthcare practitioner.
Note: If you are a new probiotic user we recommend to start slow and build up to the full dose. Jump down to the Learn More section for more info.
Cautions: If you are pregnant, nursing, or taking medication, consult your healthcare practitioner before use. Keep out of reach of children.
Storage: Store in a cool, dry place.
LEARN MORE
Why should I start slow when taking a probiotic?
Killing off harmful bacteria in your gut is one of the benefits of probiotics. You may not feel well when you first start taking probiotics because, as it dies, the harmful bacteria will release toxins in your body. This is known as a "die off reaction" or Herxheimer Reaction. Common symptoms of die off are diarrhea, bloating, and headache. As your body is working to flush out the dead bacteria and toxins, it can feel as if your symptoms are temporarily getting worse, which can be alarming, but it does get better! Symptoms go away as the toxins are flushed out and as you build up your healthy gut bacteria. We recommend starting slow when first taking probiotics to minimize die off symptoms.
Statements contained herein have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.
References
1. Fijan, S. (2014). Microorganisms with claimed probiotic properties: an overview of recent literature. International journal of environmental research and public health, 11(5), 4745-4767.
2. Turnbaugh, P. J., & Gordon, J. I. (2009). The core gut microbiome, energy balance and obesity. The Journal of physiology, 587(17), 4153-4158.
3. Evans, J. M., Morris, L. S., & Marchesi, J. R. (2013). The gut microbiome: the role of a virtual organ in the endocrinology of the host. Journal of Endocrinology, 218(3), R37-R47.
4. Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011). Human nutrition, the gut microbiome and the immune system. Nature, 474(7351), 327-336.
5. Quigley, E. M. (2010). Prebiotics and probiotics; modifying and mining the microbiota. harmacological research, 61(3), 213-218.
6. Malcolm W. Hickey, Alan J. Hillier, G. Richard Jago (1986). Transport and Metabolism of Lactose, glucose, and Galactose in Homofermentative Lactobacilli. Appl Environ Microbiol.; 51(4): 825–831.
7. Rousseaux C. et al., (2007), ‘Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors’. Nature Medicine, 13(1):35-7.
8. Ringel-Kulka T., et al., (2011). ‘Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients with Functional Bowel Disorders. A Double-blind Study’. Journal of Clinical Gastroenterology, 45: 518-525.
2. Turnbaugh, P. J., & Gordon, J. I. (2009). The core gut microbiome, energy balance and obesity. The Journal of physiology, 587(17), 4153-4158.
3. Evans, J. M., Morris, L. S., & Marchesi, J. R. (2013). The gut microbiome: the role of a virtual organ in the endocrinology of the host. Journal of Endocrinology, 218(3), R37-R47.
4. Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011). Human nutrition, the gut microbiome and the immune system. Nature, 474(7351), 327-336.
5. Quigley, E. M. (2010). Prebiotics and probiotics; modifying and mining the microbiota. harmacological research, 61(3), 213-218.
6. Malcolm W. Hickey, Alan J. Hillier, G. Richard Jago (1986). Transport and Metabolism of Lactose, glucose, and Galactose in Homofermentative Lactobacilli. Appl Environ Microbiol.; 51(4): 825–831.
7. Rousseaux C. et al., (2007), ‘Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors’. Nature Medicine, 13(1):35-7.
8. Ringel-Kulka T., et al., (2011). ‘Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients with Functional Bowel Disorders. A Double-blind Study’. Journal of Clinical Gastroenterology, 45: 518-525.